These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8883144)

  • 1. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD; Aldrovandi GM; Zack JA
    Semin Immunol; 1996 Aug; 8(4):215-21. PubMed ID: 8883144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
    Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
    J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCID-Hu mouse as a model for human lung HIV-1 infection.
    Cesbron JY; Agut H; Gosselin B; Candotti D; Raphaël M; Puech F; Grandadam M; Debré P; Capron A; Autran B
    C R Acad Sci III; 1994 Jul; 317(7):669-74. PubMed ID: 7882151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SCID-hu mouse as a model for HIV-1 infection.
    Aldrovandi GM; Feuer G; Gao L; Jamieson B; Kristeva M; Chen IS; Zack JA
    Nature; 1993 Jun; 363(6431):732-6. PubMed ID: 8515816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function.
    McCune JM
    Bone Marrow Transplant; 1992; 9 Suppl 1():74-6. PubMed ID: 1354528
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and applications of the SCID-hu mouse model.
    McCune JM
    Semin Immunol; 1996 Aug; 8(4):187-96. PubMed ID: 8883141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE
    Semin Immunol; 1996 Aug; 8(4):255-62. PubMed ID: 8883149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HIV-1 determinants for replication in vivo.
    Su L; Kaneshima H; Bonyhadi ML; Lee R; Auten J; Wolf A; Du B; Rabin L; Hahn BH; Terwilliger E; Mccune JM
    Virology; 1997 Jan; 227(1):45-52. PubMed ID: 9007057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
    Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
    Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL; Sanhadji K; Sembeil R
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR; Harrington P; Hollingshead M
    Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.
    McCune J; Kaneshima H; Krowka J; Namikawa R; Outzen H; Peault B; Rabin L; Shih CC; Yee E; Lieberman M
    Annu Rev Immunol; 1991; 9():399-429. PubMed ID: 1910684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID mouse models of human stem cell engraftment.
    Greiner DL; Hesselton RA; Shultz LD
    Stem Cells; 1998; 16(3):166-77. PubMed ID: 9617892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of murine retroviral sequences in human cell line transplanted in immunosuppressed SCID-mice.
    Cavallo R; Valente G; Jemma C; Gribaudo G; Landolfo S; Cavallo G
    New Microbiol; 1994 Jul; 17(3):195-202. PubMed ID: 7968654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
    Roth MD; Tashkin DP; Choi R; Jamieson BD; Zack JA; Baldwin GC
    J Infect Dis; 2002 Mar; 185(5):701-5. PubMed ID: 11865430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.